HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jakob R Izbicki Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2021Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
10/2020Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions.
1/2020Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.
1/2020Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers.
9/2019Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues.
1/2019Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer.
8/2018Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
9/2017Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.
1/2017Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
1/2014High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jakob R Izbicki Research Topics

Disease

143Neoplasms (Cancer)
03/2024 - 07/2002
44Adenocarcinoma
02/2024 - 04/2004
33Neoplasm Metastasis (Metastasis)
01/2024 - 01/2006
31Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 11/2002
26Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 09/2007
24Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 01/2007
21Carcinoma (Carcinomatosis)
01/2022 - 11/2008
18Pancreatitis
04/2022 - 07/2002
12Prostatic Neoplasms (Prostate Cancer)
01/2021 - 11/2013
11Chronic Pancreatitis
01/2024 - 09/2002
8Anastomotic Leak
12/2023 - 10/2019
8Carcinogenesis
12/2022 - 10/2010
8Stomach Neoplasms (Stomach Cancer)
12/2018 - 06/2009
7Pancreatic Fistula (Pancreatic Fistulas)
03/2024 - 08/2007
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2012
6Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2023 - 01/2006
6Margins of Excision
01/2021 - 01/2010
6Neoplasm Micrometastasis
03/2020 - 12/2005
6Neuroblastoma
08/2016 - 12/2007
5Sepsis (Septicemia)
01/2023 - 11/2002
5Lymphatic Metastasis
02/2022 - 02/2007
5Breast Neoplasms (Breast Cancer)
10/2016 - 01/2007
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2016 - 06/2011
5Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2011 - 07/2007
4Ascites
01/2024 - 12/2013
4Colonic Neoplasms (Colon Cancer)
10/2023 - 04/2014
4Inflammation (Inflammations)
01/2021 - 01/2009
3Wounds and Injuries (Trauma)
02/2024 - 01/2017
3Obesity
01/2024 - 01/2020
3Fibrosis (Cirrhosis)
01/2024 - 01/2021
3Incisional Hernia
10/2023 - 02/2015
3Liver Failure
01/2023 - 05/2020
3Hepatocellular Carcinoma (Hepatoma)
12/2022 - 05/2010
3Hemorrhage
02/2021 - 08/2007
3Pain (Aches)
01/2021 - 01/2006
3Colitis-Associated Neoplasms
11/2020 - 02/2009
3Necrosis
01/2020 - 12/2014
3Primitive Neuroectodermal Tumors (PNET)
01/2019 - 04/2011
3Lung Neoplasms (Lung Cancer)
05/2015 - 03/2009
3Squamous Cell Neoplasms (Squamous Cell Cancer)
02/2007 - 09/2003

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
12/2022 - 12/2005
26Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2008
13DNA (Deoxyribonucleic Acid)IBA
01/2017 - 01/2003
10Monoclonal AntibodiesIBA
01/2019 - 12/2004
10Trastuzumab (Herceptin)FDA Link
12/2018 - 01/2007
8RNA (Ribonucleic Acid)IBA
01/2024 - 01/2008
7Interleukin-22 (IL-22)IBA
03/2024 - 01/2020
7AntibodiesIBA
12/2023 - 11/2002
7Indicators and Reagents (Reagents)IBA
04/2022 - 09/2003
7MidkineIBA
01/2021 - 07/2007
7Cell Adhesion MoleculesIBA
09/2019 - 03/2006
6Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
08/2016 - 10/2011
6Hemoglobins (Hemoglobin)IBA
08/2014 - 11/2003
6Chemokine ReceptorsIBA
09/2013 - 08/2011
5Transcription Factors (Transcription Factor)IBA
02/2024 - 04/2010
5Polysaccharides (Glycans)IBA
01/2024 - 12/2014
5CytokinesIBA
12/2023 - 11/2002
5Epithelial Cell Adhesion MoleculeIBA
04/2022 - 12/2005
5Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 09/2010
5GemcitabineFDA Link
11/2017 - 09/2010
5Messenger RNA (mRNA)IBA
09/2017 - 01/2003
4AntigensIBA
01/2024 - 01/2003
4Keratins (Keratin)IBA
03/2020 - 03/2009
4CeruletideIBA
08/2014 - 04/2005
4Starch (Cornstarch)IBA
08/2014 - 04/2005
4Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
04/2012 - 03/2006
4Peptides (Polypeptides)IBA
07/2010 - 11/2002
3Tn antigenIBA
01/2024 - 05/2015
3Glycoproteins (Glycoprotein)IBA
10/2022 - 12/2014
3C-Reactive ProteinIBA
11/2021 - 01/2016
3AlbuminsIBA
11/2021 - 01/2016
3Immune Checkpoint InhibitorsIBA
09/2021 - 08/2019
3Anti-Bacterial Agents (Antibiotics)IBA
10/2020 - 12/2011
3Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
03/2020 - 12/2008
3Phosphotransferases (Kinase)IBA
01/2019 - 01/2013
3Leucovorin (Folinic Acid)FDA Link
11/2017 - 09/2010
3Glycodeoxycholic AcidIBA
02/2016 - 01/2009
3LigandsIBA
02/2015 - 07/2012
3ErbB Receptors (EGF Receptor)IBA
10/2014 - 09/2010
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2014 - 07/2007
3Neoplasm Antigens (Tumor Antigens)IBA
12/2013 - 11/2002
3Chemokine CXCL12IBA
09/2013 - 07/2012
3ParaffinIBA
02/2012 - 01/2006

Therapy/Procedure

50Therapeutics
01/2024 - 09/2002
19Esophagectomy
05/2023 - 06/2006
10Pancreatectomy
03/2024 - 12/2006
10Drug Therapy (Chemotherapy)
01/2023 - 09/2011
9Neoadjuvant Therapy
12/2023 - 02/2007
8Laparotomy
02/2024 - 01/2006
6Lymph Node Excision (Lymph Node Dissection)
06/2023 - 09/2006
6Adjuvant Chemotherapy
01/2021 - 11/2008
5Pancreaticoduodenectomy
01/2021 - 07/2002
4Operative Surgical Procedures
02/2024 - 11/2012
4Length of Stay
12/2023 - 01/2006
4Aftercare (After-Treatment)
02/2022 - 08/2014
3Critical Care (Surgical Intensive Care)
11/2023 - 10/2020
3Transplantation
11/2023 - 06/2010
3Stents
08/2022 - 06/2021
3Prostatectomy (Retropubic Prostatectomy)
01/2019 - 01/2010
3Minimally Invasive Surgical Procedures
10/2018 - 11/2008